Page 525 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 5

114. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to 128. Reardon MJ, Carr CL, Diamond A, et al. Ischemic left ventricu-
aspirin reduces the incidence of myocardial infarction and lar free wall rupture: prediction, diagnosis, and treatment. Ann
death in patients with unstable angina. A meta-analysis. JAMA. Thorac Surg. 1997;64:1509-1513.
1996;276:811-815. 129. Killen DA, Piehler JM, Borkon AM, Gorton ME, Reed WA.
115. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of Early repair of postinfarction ventricular septal rupture. Ann
low-molecular-weight heparin with unfractionated heparin Thorac Surg. 1997;63:138-142.
for unstable coronary artery disease. Efficacy and Safety of 130. Khan SS, Gray RJ. Valvular emergencies. Cardiol Clin.
Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events 1991;9:689-709.
Study Group. N Engl J Med. 1997;337:447-452.
131. Bolooki H. Emergency cardiac procedures in patients in car-
116. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin diogenic shock due to complications of coronary artery disease.
prevents death and cardiac ischemic events in unstable angina/ Circulation. 1989;79:I137-I148.
non-Q-wave myocardial infarction. Results of the throm-
bolysis in myocardial infarction (TIMI) 11B trial. Circulation. 132. Carabello BA. The current therapy for mitral regurgitation.
1999;100:1593-1601. J Am Coll Cardiol. 2008;52:319-326.
117. Antman EM, Cohen M, Radley D, et al. Assessment of the 133. Zehender M, Kasper W, Kauder E, et al. Right ventricular
treatment effect of enoxaparin for unstable angina/non-Q-wave infarction as an independent predictor of prognosis after
myocardial infarction. TIMI 11B-ESSENCE meta-analysis. acute inferior myocardial infarction. N Engl J Med. 1993;328:
Circulation. 1999;100:1602-1608. 981-988.
118. FRagmin and Fast Revascularisation during InStability in Coronary 134. Dell’Italia LJ, Starling MR, Blumhardt R, Lasher JC, O’Rourke RA.
artery disease Investigators. Invasive compared with non-invasive Comparative effects of volume loading, dobutamine, and nitro-
treatment in unstable coronary-artery disease: FRISC II prospec- prusside in patients with predominant right ventricular infarc-
tive randomised multicentre study. Lancet. 1999;354:708-715. tion. Circulation. 1985;72:1327-1335.
119. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and pro- 135. Bowers TR, O’Neill WW, Grines C, Pica MC, Safian RD,
visional glycoprotein IIb/IIIa blockade compared with heparin Goldstein JA. Effect of reperfusion on biventricular function
and planned glycoprotein IIb/IIIa blockade during percuta- and survival after right ventricular infarction. N Engl J Med.
neous coronary intervention: REPLACE-2 randomized trial. 1998;338:933-940.
JAMA. 2003;289:853-863. 136. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C,
120. Platelet Receptor Inhibition in Ischemic Syndrome Management Gore JM. Temporal trends in cardiogenic shock complicat-
(PRISM) Study Investigators. A Comparison of Aspirin plus ing acute myocardial infarction. N Engl J Med. 1999;340:
Tirofiban with Aspirin plus Heparin for Unstable Angina. 1162-1168.
N Engl J Med. 1998;338:1498-1505. 137. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum
121. The PURSUIT Trial Investigators. Inhibition of platelet glyco- of cardiogenic shock and effect of early revascularization on
protein IIb/IIIa with eptifibatide in patients with acute coronary mortality. Results of an International Registry. Circulation.
syndromes. N Engl J Med. 1998;339:436-443. 1995;91:873-881.
122. CAPTURE Investigators. Randomised placebo-controlled 138. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary
trial of abciximab before and during coronary intervention reperfusion therapy for cardiogenic shock: the GUSTO-I trial
in refractory unstable angina: the CAPTURE Study. Lancet. experience. The GUSTO-I Investigators. Global Utilization of
1997;349:1429-1435. Streptokinase and Tissue Plasminogen Activator for Occluded
123. Boden WE, O’Rourke RA, Crawford MH, et al. Outcomes in Coronary Arteries. J Am Coll Cardiol. 1995;26:668-674.
patients with acute non-Q-wave myocardial infarction ran- 139. De Backer D, Biston P, Devriendt J, et al. Comparison of dopa-
domly assigned to an invasive as compared with a conservative mine and norepinephrine in the treatment of shock. N Engl J
management strategy. N Engl J Med. 1998;338:1785-1792. Med. 2010;362:779-789.
124. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison 140. Hollenberg SM, Hoyt JW. Pulmonary artery catheters in cardio-
of early invasive and conservative strategies in patients with vascular disease. New Horizons. 1997;5:207-213.
unstable coronary syndromes treated with the glycoprotein IIb/ 141. Russ MA, Prondzinsky R, Christoph A, et al. Hemodynamic
IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887. improvement following levosimendan treatment in patients
125. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional with acute myocardial infarction and cardiogenic shock. Crit
versus conservative treatment for patients with unstable angina Care Med. 2007;35:2732-2739.
or non-ST-elevation myocardial infarction: the British Heart 142. Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Ferrer-Hita
Foundation RITA 3 randomised trial. Randomized Intervention JJ, Abreu-Gonzalez P, Munoz MB. Cardiogenic shock after
Trial of unstable Angina. Lancet. 2002;360:743-751. primary percutaneous coronary intervention: effects of levosi-
126. Hirsch A, Windhausen F, Tijssen JG, Verheugt FW, Cornel JH, mendan compared with dobutamine on haemodynamics. Eur J
de Winter RJ. Long-term outcome after an early invasive versus Heart Failure. 2006;8:723-728.
selective invasive treatment strategy in patients with non-ST- 143. Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan
elevation acute coronary syndrome and elevated cardiac troponin vs dobutamine for patients with acute decompensated heart
T (the ICTUS trial): a follow-up study. Lancet. 2007;369:827-835. failure: the SURVIVE Randomized Trial. JAMA. 2007;297:
127. Mehta SR, Granger CB, Boden WE, et al. Early versus delayed 1883-1891.
invasive intervention in acute coronary syndromes. N Engl J 144. Willerson JT, Curry GC, Watson JT, et al. Intraaortic balloon
Med. 2009;360:2165-2175. counterpulsation in patients in cardiogenic shock, medically

Section03-O-ref.indd 5 1/20/2015 7:10:24 AM